Eur J Anaesthesiol 42(1):135
LD was also proposed to reduce the size of the uterine in UF by suppressing angiogenesis via the reduction of VEGF expression and the downregulation of HIF-1
Next, structural disorders of the large intestine were examined using HE-stained samples
How This Compares to Similar Drugs Tirzepatide's Phase 3 trials began in 2019, FDA submission happened in mid-2022, and approval came in May 2022 (for diabetes) and November 2023 (for obesity)
Primary and secondary outcomes We assessed two co-primary outcomes, which we identified by using inpatient diagnostic codes and mortality codes in the primary position (ICD-10 codes for the outcomes can be found in supplementary table B )
Groups in which it may be more relevant The relevance of carnitine may increase when dietary intake is low (for example, in strictly plant-based diets) or in clinical situations that alter homeostasis (e.g., renal disease with dialysis, certain medications)